Phase
Condition
Aneurysm
Heart Disease
Cardiovascular Disease
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient or legally authorized representative (LAR) provides written authorizationand/or consent per institution and geographical requirements
Patient has been or is intended to be treated with an eligible registry device
Patient is age ≥ 18 years at time of informed consent signature.
Exclusion
Exclusion Criteria:
Patient who is, at the time of consent, unlikely to be available for standard ofcare (SOC) follow-up visits as defined by the site's guidelines and procedures.
Patient with exclusion criteria required by local law.
Patient is currently enrolled in or plans to enroll in any concurrent drug and/ordevice study within 12 months of Together Registry enrollment. Subjects cannot beenrolled in another Together Registry module protocol.
Study Design
Study Description
Connect with a study center
Medizinische Universitat Wien
Vienna,
AustriaActive - Recruiting
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona
Ancona,
ItalyActive - Recruiting
Fondazione IRCCS Policlinico San Matteo
Pavia,
ItalyActive - Recruiting
VU Medical Center Amsterdam
Amsterdam,
NetherlandsActive - Recruiting
VieCuri Medical Center
Venlo,
NetherlandsActive - Recruiting
St. Vincent Medical Group, Inc.
Indianapolis, Indiana 46260
United StatesActive - Recruiting
McLaren Heatlh Care Corporation
Bay City, Michigan 48708
United StatesActive - Recruiting
Mission Hospital
Asheville, North Carolina 28801
United StatesActive - Recruiting
Columbia Medical Center of Plano
Plano, Texas 75075
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.